Human CD20 Protein-VLP, Accession: P11836

Overview

General Description

Recombinant Human CD20 Protein-VLP is expressed from HEK293.It contains Met1-Pro297.

Biotinylated

Specifications

Target

CD20 VLP

Synonyms

MS4A1; CD20; MS4A-1; B1; Bp35; CD20 receptor; CD20S7; CVID5; LEU-16; Ly-44; MS4A2; S7

Accession

P11836

Species

Human

Exact Sequence

Met1-Pro297

Molecular Weight

The target protein has a predicted MW of 34.3 kDa.

Activity

Immobilized Human CD20 VLP at 5ug/ml (100ul/Well) on plate on the plate. Dose response curve for Rituximab, hFc Tag with the EC50 of 8.7ng/ml determined by ELISA (QC Test). See testing image for detail.

Product Tag

Express System

HEK293

Purity

> 95% as determined by HPLC

Endotoxin

Less than 1EU per ug by the LAL method.

Shipping, Reconstitution & Storage

Appearance

Lyophilized

Shipping Conditions

Shipped at ambient temperature.

Formulation

Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.Notice: If you need it for immunization, Do Not use any adjuvant.

Reconstitution

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

Stability & Storage

Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

Declaration

This product is branded by ChemWhat and sold through our website and here is the corresponding link ChemWhat Official Website.

This product is sold exclusively through our sales company Watson International Limited (Ltd), and please click the link below for details. (https://www.watson-int.com/), and here is the corresponding link https://www.watson-int.com/Human-CD20-Protein-VLP-accession-P11836/.